Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.56 USD | +2.23% | -9.90% | -3.56% |
Mar. 13 | Top Premarket Decliners | MT |
Mar. 12 | JPMorgan Adjusts Price Target on iTeos Therapeutics to $27 From $29, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.56% | 370M | |
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |
- Stock Market
- Equities
- ITOS Stock
- News iTeos Therapeutics, Inc.
- Piper Sandler Adjusts iTeos Therapeutics' Price Target to $42 From $50, Reiterates Overweight Rating